BioVentrix has launched a myocardial anchoring system for patients with ischemic cardiomyopathy. The new technology, Revivent, is designed for use in less invasive ventricular enhancement (LIVE) procedures to improve the function of ...
BioCardia has announced positive results from a Phase I/II trial of its Helical Infusion system, designed to deliver donor's (allogeneic) or treated patient's (autologous) adult mesenchymal stem cells (MSCs) via transendocardial stem cell ...
Tags: Helical Infusion system, stem cell injection, device, Infusion System